Gastrointestinal Stromal Tumours Test

The GIST test works by analysing the DNA of tumour cells to check for specific gene mutations that may be causing uncontrolled cell growth.

• The test detects mutations in genes such as KIT, PDGFRA, and other related genes.
• Identifies whether the tumour is likely to respond to targeted therapies like tyrosine kinase inhibitors (TKIs).
• Helps doctors distinguish GIST from other similar tumours for a more accurate diagnosis.
• Guides personalised treatment plans to improve patient outcomes and disease management.

• Mutation Detected: A genetic mutation was found in KIT, PDGFRA, or other genes, indicating the presence of GIST. Your doctor will use this information to determine the best treatment approach.
• No Mutation Detected: No known mutations were found, but additional tests may be required to confirm the diagnosis.
• Variant of Uncertain Significance (VUS): A genetic change was found, but its impact is unclear. Further analysis or follow-up testing may be needed.

• Comprehensive Genetic Analysis: Detects key KIT, PDGFRA, and other gene mutations for precise diagnosis and treatment selection.
• Accurate & Reliable Results: Utilises advanced genomic technology for highly sensitive and specific mutation detection.
• Essential for Personalised Treatment: Helps doctors select the right targeted therapy, reducing unnecessary treatments.
• Quick Turnaround Time: Delivers fast results, allowing doctors to initiate treatment promptly.
• Trusted by Leading Hospitals & Oncologists: MedGenome follows international quality standards, ensuring clinically validated and reliable genetic testing.